-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Mesenchymal stem cells in neurological diseases
Ibrahim Kassis, Panayiota Petrou, Adi Vaknin-Dembinsky, Dimitrios Karussis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Mesenchymal stem cells in neurological diseases
Ibrahim Kassis, Panayiota Petrou, Adi Vaknin-Dembinsky, Dimitrios Karussis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Mesenchymal stem cells in neurological diseases
Ibrahim Kassis, Panayiota Petrou, Adi Vaknin-Dembinsky, Dimitrios Karussis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Mesenchymal stem cells in neurological diseases
Ibrahim Kassis, Panayiota Petrou, Adi Vaknin-Dembinsky, Dimitrios Karussis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Mesenchymal stem cells in neurological diseases
Ibrahim Kassis, Panayiota Petrou, Adi Vaknin-Dembinsky, Dimitrios Karussis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Mesenchymal stem cells in neurological diseases
Ibrahim Kassis, Panayiota Petrou, Adi Vaknin-Dembinsky, Dimitrios Karussis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Mesenchymal stem cells in neurological diseases
Ibrahim Kassis, Panayiota Petrou, Adi Vaknin-Dembinsky, Dimitrios Karussis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Mesenchymal stem cells in neurological diseases
Ibrahim Kassis, Panayiota Petrou, Adi Vaknin-Dembinsky, Dimitrios Karussis
Review: Clinical Trail Outcomes: Clinical Investigation